Navigation Links
ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
Date:11/10/2011

MOUNTAIN VIEW, Calif., Nov. 10, 2011 /PRNewswire/ -- ChemoCentryx, Inc. today announced positive preclinical results for its novel CCR2 antagonist at the 44th Annual Meeting of the American Society of Nephrology. CCR2 inhibition in diabetic mice resulted in rapid and robust improvements of albuminuria, serum markers of renal function, and hyperglycemia.  These data were highlighted today in a poster presentation titled "CCR2 Inhibition in Diabetic Mice Results in a Rapid and Robust Improvement of Renal Function" in Philadelphia, PA. CCX140, the Company's most advanced CCR2 antagonist is currently in Phase II clinical trials for diabetic nephropathy.  

"These results further support the clinical evaluation of CCR2 antagonists such as our lead independent drug candidate, CCX140, in renal disease," stated Thomas J. Schall, President and CEO, ChemoCentryx. "Diabetic nephropathy is the leading cause of end-stage renal disease, for which there are no current treatment options that halt or reverse disease progression. We believe CCR2 antagonism represents a potential new treatment option which would delay or prevent the onset of end-stage renal disease and therefore offer significant pharmaco-economic benefits."

Results and Study Design

Results show that treatment with a CCR2 inhibitor significantly reduced urinary albumin excretion (UAER) and albumin:creatinine ratio (ACR). Statistically significant improvements in UAER and urinary ACR were noted as early as 48 hours after initiation of treatment. Serum markers of renal function (serum creatinine and blood urea nitrogen) were also improved after 14 days of treatment. The benefits seen on renal function were observed at lower doses than those required for anti-glycemic benefit.

Male db/db mice (age 12-19 weeks) were dosed daily with the CCR2 antagonist or matching vehicle. Weekly assessments included body weight, fasting plasma glucose, serum clinical chemistry, and 2
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development
2. ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist
3. ChemoCentryxs Traficet-EN(TM) Phase II/III Induction Phase Data in Crohns Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week
4. ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California
5. ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR)
6. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
7. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
8. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
9. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
10. GeoVax Presents Data at AIDS Vaccine 2008 Conference
11. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... OH (PRWEB) November 25, 2014 Miles ... has joined the Graphel Carbon Products team as Sales/Marketing ... sales, marketing, and customer service for the graphite industry. ... Miles to our team,” stated Dave Trinkley, VP of ... “His wide range of experience in the graphite industry, ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... Acid Industry is an in-depth research report on ... analysis, the report introduces Palmitic Acid, basic information, ... overview, policy analysis, and news analysis, etc. ... report analyzes Palmitic Acid market in ...
(Date:11/26/2014)... Theravalues Corporation annuncia con orgoglio il lancio di Theracurmin® ... Europe 2014 (dal 2 al 4 dicembre, ... con la maggiore biodisponibilità di sempre, con una combinazione ... norme europee. La curcumina è un pigmento ... longa ) che è stata associata con attività antiossidanti, ...
(Date:11/24/2014)... UAE, November 24, 2014 Five ... Bin Rashid Al Maktoum Awards for Medical Sciences", in ... Dubai, United Arab Emirates , on 15 December ... , The Carter Center which won the ... actively involved in numerous programs that aim to improve ...
Breaking Biology Technology:Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3Five US Winners Among Recipients of Hamdan Medical Awards 2
... Strategic Fund L.P. invests $10 million in Radius-, ... ("Radius"),announced today that it has granted Novartis (NYSE: ... worldwide license (except Japan) to develop and,commercialize all ... a proprietary analog of hPTHrP (human parathyroid,hormone-related protein) ...
... ultraviolet laser light has been used for years to ... extent of their thermal motion. Now, applying a different ... the National Institute of Standards and Technology (NIST) have ... miniature mechanical oscillator containing more than a quadrillion atoms, ...
... ST. LOUIS, Sept. 14 Sigma-Aldrich Corporation,(Nasdaq: SIAL ... Life Sciences,Conference on Tuesday, September 25th at 1:00 PM ... via live audio broadcast over the,Internet available at ... this file. For the webcast on, http://ir.sigmaaldrich.com users ...
Cached Biology Technology:Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis 2'Radio wave cooling' offers new twist on laser cooling 2
(Date:11/5/2014)... biology in the UTSA College of Sciences, is ... to receive a two-year $300,00 National Science Foundation ... The funding supports President Obama,s BRAIN Initiative, a ... technology that will demystify complex brain processes. ... are broken into the interactions of multiple components, ...
(Date:11/5/2014)... Brazil -Individuals show great diversity in their ability to ... females greatly differ in their perceptual evaluation of odors, ... tests. , Sex differences in olfactory detection ... may be connected to one,s perception of smell, which ... women,s olfactory superiority has been suggested to be cognitive ...
(Date:11/4/2014)... amount of death at the right time might actually ... research that could help in understanding animal populations, pest ... a paper in the journal Trends in Ecology ... colleagues conclude that the kind of positive population effect ... or mortality, depends on the size and developmental stage ...
Breaking Biology News(10 mins):UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3The female nose always knows: Do women have more olfactory neurons? 2When less is more: Death in moderation boosts population density in nature 2
... featuring lab tours and scientific presentations on a variety ... medical countermeasures, vaccine adjuvant safety, and salmonella. Tailor your ... story ideas and spot news announcements on both days ... Margaret A. Hamburg, M.D., FDA Chief Scientist Jesse Goodman, ...
... , Johns Hopkins researchers have created a synthetic protein that, ... within the body where cancer, arthritis and other serious medical ... a new type of diagnostic imaging technology and may someday ... the body where signs of disease have been found. In ...
... mood for food can be changed by a restaurant,s choice ... calorie intake, according to a new study., "When we did ... music and lighting led diners to eat 175 fewer calories ... Wansink, professor of marketing and director of Cornell University,s Food ...
Cached Biology News:FDA's 2012 Science Writers Symposium 2Collagen-seeking synthetic protein could lead doctors to tumor locations 2Collagen-seeking synthetic protein could lead doctors to tumor locations 3
Collected from animals of U.S. origin.Collected from animals of U.S. origin. *Can be used in cell growth studies and immunoassays. *Sterility tested, * Mycoplasma tested upon request, *Endoto...
...
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
... reagent for Virus isolation ... unique water insoluble Elastomeric ... and chaotropes; Engineered to ... viruses while preserving infectivity; ...
Biology Products: